Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment | Synapse

March 12, 2004Open Access

Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Patients with advanced mEOC have a poorer response to platinum-based first-line chemotherapy compared with patients with other histologic subtypes of EOC, and their survival is worse. Specific alternative therapeutic approaches should be sought for this group of patients, perhaps involving fluorouracil-based chemotherapy.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Hess et al. (Fri,) studied this question.

synapsesocial.com/papers/69d8cfb133ca018b39ae419d https://doi.org/https://doi.org/10.1200/jco.2004.08.078

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Primary Appendiceal Malignancy Mimicking Advanced Stage Ovarian Carcinoma: A Case Series2000 · 23 citations
2WHO Handbook for Reporting Results of Cancer Treatment1982 · 2,204 citations
3Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973‐87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina1994 · 420 citations
4Cytotoxic agents active against mucinous adenocarcinoma of the ovary.1998 · 24 citations
5The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian Cancer1995 · 223 citations